<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vsp</journal-id><journal-title-group><journal-title xml:lang="ru">Вопросы современной педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Current Pediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-5527</issn><issn pub-type="epub">1682-5535</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/vsp.v12i1.569</article-id><article-id custom-type="elpub" pub-id-type="custom">vsp-380</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБМЕН ОПЫТОМ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXCHANGE OF EXPERIENCE</subject></subj-group></article-categories><title-group><article-title>ОСТРЫЕ РЕСПИРАТОРНЫЕ ИНФЕКЦИИ У ДЕТЕЙ С АЛЛЕРГИЕЙ: ПРОБЛЕМЫ ВЫБОРА АНТИБАКТЕРИАЛЬНОГО ПРЕПАРАТА</article-title><trans-title-group xml:lang="en"><trans-title>ACUTE RESPIRATORY INFECTIONS IN CHILDREN WITH ALLERGY: PROBLEMS WITH ANTIBACTERIAL AGENT CHOICE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайцева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaitseva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">olga6505963@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Московский государственный медико-стоматологический университет им. А.И. Евдокимова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow State University of Medicine and Dentistry named after A.I. Evdokimov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>03</day><month>02</month><year>2013</year></pub-date><volume>12</volume><issue>1</issue><issue-title>Вопросы современной педиатрии</issue-title><fpage>131</fpage><lpage>135</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зайцева О.В., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Зайцева О.В.</copyright-holder><copyright-holder xml:lang="en">Zaitseva O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vsp.spr-journal.ru/jour/article/view/380">https://vsp.spr-journal.ru/jour/article/view/380</self-uri><abstract><p>Острые респираторные инфекции — самые распространенные заболевания в детском возрасте, причем дети, склонные к аллергии, болеют ими чаще и тяжелее сверстников. Респираторные инфекции у лиц, склонных к аллергии, без адекватного лечения часто принимают осложненный или хронический характер течения. Своевременная и адекватная терапия данных состояний способствует более быстрому выздоровлению и предупреждает развитие осложнений. Современные макролидные антибиотики — препараты выбора при лечении острых респираторных инфекций вирусно-бактериальной или бактериальной этиологии у детей с аллергией. Одним из наиболее часто назначаемых антибактериальных препаратов в аллергологической практике является оригинальный азитромицин. Это связано с его высокой эффективностью в отношении внебольничных возбудителей респираторных инфекций, в т.ч. атипичных, значительно более высокими и стабильными концентрациями в тканях, длительным периодом полувыведения с возможностью приема 1 раз в сут, а также низкой вероятностью развития аллергических реакций. Целесообразность применения азитромицина при аллергических заболеваниях, кроме того, обусловлена неантибиотическими свойствами: противовоспалительным и иммуномодулирующим.</p></abstract><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>острые респираторные инфекции</kwd><kwd>аллергия</kwd><kwd>макролиды</kwd><kwd>азитромицин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>acuterespiratory infections</kwd><kwd>allergy</kwd><kwd>macrolides</kwd><kwd>azithromycin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Salvo F., De Sarro A., Caputi A. P., Polimeni G. Amoxicillin and amoxicillin plus clavulanate: a safety review. Exp. Opin. Drug. Saf. 2009; 8 (1): 111–118.</mixed-citation><mixed-citation xml:lang="en">Salvo F., De Sarro A., Caputi A. P., Polimeni G. Amoxicillin and amoxicillin plus clavulanate: a safety review. Exp. Opin. Drug. Saf. 2009; 8 (1): 111–118.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Demoly P., Benahmed S., Valembois M. et al. Allergy to macro lide antibiotics. Review of the literature. Presse Med. 2000; 29 (6): 321–326.</mixed-citation><mixed-citation xml:lang="en">Demoly P., Benahmed S., Valembois M. et al. Allergy to macro lide antibiotics. Review of the literature. Presse Med. 2000; 29 (6): 321–326.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lee C. E., Zembower T. R., Fotis M. A. et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch. Intern. Med. 2000; 160 (18): 2819–2822.</mixed-citation><mixed-citation xml:lang="en">Lee C. E., Zembower T. R., Fotis M. A. et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch. Intern. Med. 2000; 160 (18): 2819–2822.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kozlov R. S., Krechikova O. I. et al. Dynamics of S. Pneumonia resistance to antibiotics in Russia during 1999–2009: results of multicenter prospective study PeGAS. Clinical microbiology and antimicrobial chemotherapy. 2010; 12 (4): 329–341.</mixed-citation><mixed-citation xml:lang="en">Kozlov R. S., Krechikova O. I. et al. Dynamics of S. Pneumonia resistance to antibiotics in Russia during 1999–2009: results of multicenter prospective study PeGAS. Clinical microbiology and antimicrobial chemotherapy. 2010; 12 (4): 329–341.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Reshedko G. K., Kozlov R. S. The state of resistance to antiinfection drugs in Russia. In a book: Practical guideline on antiinfection chemotherapy. Edited by L. S. Strachunskiy, Yu. B. Belousov, R. S. Kozlov. Moscow. 2007. Pp. 32–47.</mixed-citation><mixed-citation xml:lang="en">Reshedko G. K., Kozlov R. S. The state of resistance to antiinfection drugs in Russia. In a book: Practical guideline on antiinfection chemotherapy. Edited by L. S. Strachunskiy, Yu. B. Belousov, R. S. Kozlov. Moscow. 2007. Pp. 32–47.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Strachunskiy L. S., Kozlov S. N. Macrolides in modern clinical practice. Smolensk: Rusich. 1998. 304 pp.</mixed-citation><mixed-citation xml:lang="en">Strachunskiy L. S., Kozlov S. N. Macrolides in modern clinical practice. Smolensk: Rusich. 1998. 304 pp.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bauernfeind A. In vitro activity of diritrimycin in comparison with other new and established macrolides. J. Antimicrob. Chemother. 1993; 31 (Suppl.): 39–49.</mixed-citation><mixed-citation xml:lang="en">Bauernfeind A. In vitro activity of diritrimycin in comparison with other new and established macrolides. J. Antimicrob. Chemother. 1993; 31 (Suppl.): 39–49.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Foulds G., Shepard R., Johnson R. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 1990; 25 (Suppl. A): 73–82.</mixed-citation><mixed-citation xml:lang="en">Foulds G., Shepard R., Johnson R. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 1990; 25 (Suppl. A): 73–82.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Practical guideline on anti-infection chemotherapy. Edited by Strachunskiy L. S., Belousov Yu. B., Kozlov S. N. Moscow: Borges. 2002. 379 pp.</mixed-citation><mixed-citation xml:lang="en">Practical guideline on anti-infection chemotherapy. Edited by Strachunskiy L. S., Belousov Yu. B., Kozlov S. N. Moscow: Borges. 2002. 379 pp.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Handbook on antimicrobial therapy. Smolensk. 2006.</mixed-citation><mixed-citation xml:lang="en">Handbook on antimicrobial therapy. Smolensk. 2006.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Strachunskiy L. S., Kozlov S. N. Macrolides in modern clinical practice. Smolensk. 1998.</mixed-citation><mixed-citation xml:lang="en">Strachunskiy L. S., Kozlov S. N. Macrolides in modern clinical practice. Smolensk. 1998.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Veselov A. V., Kozlov R. S. Clinical microbiology and antimicrobial chemotherapy. 2006; 8 (1): 18.</mixed-citation><mixed-citation xml:lang="en">Veselov A. V., Kozlov R. S. Clinical microbiology and antimicrobial chemotherapy. 2006; 8 (1): 18.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Treadway G., Pontani D. J. Antimicrob. Chemother. 1996; 7 (Suppl. C): 143.</mixed-citation><mixed-citation xml:lang="en">Treadway G., Pontani D. J. Antimicrob. Chemother. 1996; 7 (Suppl. C): 143.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zarogoulidis P., Papanas N., Kioumis I., Chatzaki E., Maltezos E., Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur. J. Clin. Pharmacol. Epub. 2011.</mixed-citation><mixed-citation xml:lang="en">Zarogoulidis P., Papanas N., Kioumis I., Chatzaki E., Maltezos E., Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur. J. Clin. Pharmacol. Epub. 2011.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Antibiotics and the Lung. Eur. Respir. Monograph. M. Cazzola, F. Blasi, S. Ewig (eds.). 2004; 9: 28.</mixed-citation><mixed-citation xml:lang="en">Antibiotics and the Lung. Eur. Respir. Monograph. M. Cazzola, F. Blasi, S. Ewig (eds.). 2004; 9: 28.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Labro M. T. Antibiotics as anti-inflammatory drugs. Curr. Opin. Investig. Drugs. 2002; 3: 61–68.</mixed-citation><mixed-citation xml:lang="en">Labro M. T. Antibiotics as anti-inflammatory drugs. Curr. Opin. Investig. Drugs. 2002; 3: 61–68.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Tamaoki J. The effects of macrolides on inflammatory cells. Chest. 2004; 125 (Suppl.): 41–51.</mixed-citation><mixed-citation xml:lang="en">Tamaoki J. The effects of macrolides on inflammatory cells. Chest. 2004; 125 (Suppl.): 41–51.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Equi A., Balfour-Lynn I. M., Bush A., Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial. Lancet. 2002; 360: 978–984.</mixed-citation><mixed-citation xml:lang="en">Equi A., Balfour-Lynn I. M., Bush A., Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial. Lancet. 2002; 360: 978–984.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Amsden G. W. Anti-inflammatory effects of macrolides — an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions. J. Antimicrob. Chemother. 2005; 55 (1): 10–21.</mixed-citation><mixed-citation xml:lang="en">Amsden G. W. Anti-inflammatory effects of macrolides — an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions. J. Antimicrob. Chemother. 2005; 55 (1): 10–21.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Harris J. A. et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr. Infect. Dis. J. 1998; 17 (10): 865.</mixed-citation><mixed-citation xml:lang="en">Harris J. A. et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr. Infect. Dis. J. 1998; 17 (10): 865.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Wubbel L. et al. Etiology and treatment of community-acquired pneu monia in ambulatory children. Pediatr. Infect. Dis. J. 1999; 18 (2): 98.</mixed-citation><mixed-citation xml:lang="en">Wubbel L. et al. Etiology and treatment of community-acquired pneu monia in ambulatory children. Pediatr. Infect. Dis. J. 1999; 18 (2): 98.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Barsic B. Abstracts of the 20th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases). Vienna, Austria. April 10–13. 2010. 174 p.</mixed-citation><mixed-citation xml:lang="en">Barsic B. Abstracts of the 20th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases). Vienna, Austria. April 10–13. 2010. 174 p.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
